IRadimed

IRadimed Liabilities

The The Liabilities of IRadimed (IRMD) as of Nov 2, 2026 is 14.16 M USD. In the previous year, The Liabilities was 11.51 M USD — a change of 23.04% (higher).

Liabilities

14.16 MUSD

YoY

23.04%

Last updated:

In 2025, IRadimed's total liabilities amounted to 14.16 M USD, a 23.04% difference from the 11.51 M USD total liabilities in the previous year.

The IRadimed Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
6.50 M USD
Jan 1, 2019
11.20 M USD
Jan 1, 2020
9.68 M USD
Jan 1, 2021
10.71 M USD
Jan 1, 2022
11.84 M USD
Jan 1, 2023
20.74 M USD
Jan 1, 2024
11.51 M USD
Jan 1, 2025
14.16 M USD
The IRadimed Liabilities history
YEARLiabilitiesYoY
14.16 MUSD+23.04%
11.51 MUSD-44.51%
20.74 MUSD+75.12%
11.84 MUSD+10.58%
10.71 MUSD+10.59%
9.68 MUSD-13.59%
11.20 MUSD+72.47%
6.50 MUSD+6.82%
6.08 MUSD+14.63%
5.31 MUSD+60.23%
3.31 MUSD+36.88%
2.42 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing IRadimed's Liabilities

IRadimed's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating IRadimed's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing IRadimed's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

IRadimed's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in IRadimed’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about IRadimed stock

The Liabilities of IRadimed is 14.16 M USD in 2025.

The Liabilities of IRadimed changed from 11.51 M USD to 14.16 M USD, representing a 23.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities IRadimed since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's IRadimed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — IRadimed

All Key Metrics — IRadimed